(2010). Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. http://doi.org/10.1016/s0140-6736(09)61969-3.
(2012). Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs. Diabetes Obes Metab. http://doi.org/10.1111/j.1463-1326.2011.01552.x.
(2012). What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-3034.
(2012). Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-1690.
(2013). The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child Adolesc Psychiatry Ment Health. http://doi.org/10.1186/1753-2000-7-34.
(2013). Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2013-004025.
(2013). The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab. http://doi.org/10.1111/dom.12123.
(2013). Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-3042.
(2013). Omega-3 Fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retrospective, matched-cohort study. Clin Ther. http://doi.org/10.1016/j.clinthera.2012.11.008.
(2014). The effect of withdrawal of rosiglitazone on treatment pathways, diabetes control and patient outcomes: a retrospective cohort study. J Diabetes Complications. http://doi.org/10.1016/j.jdiacomp.2014.01.007.